210 related articles for article (PubMed ID: 25380164)
21. Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in Israel.
Melzer Cohen C; Hallén N; Chodick G; Bourvine L; Waner T; Karasik A
Value Health Reg Issues; 2020 Sep; 22():83-92. PubMed ID: 32798839
[TBL] [Abstract][Full Text] [Related]
22. Economic analysis of delivering primary health care services through community health workers in 3 North Indian states.
Prinja S; Jeet G; Verma R; Kumar D; Bahuguna P; Kaur M; Kumar R
PLoS One; 2014; 9(3):e91781. PubMed ID: 24626285
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
[TBL] [Abstract][Full Text] [Related]
24. Cost of adult chronic rhinosinusitis: A systematic review.
Smith KA; Orlandi RR; Rudmik L
Laryngoscope; 2015 Jul; 125(7):1547-56. PubMed ID: 25640115
[TBL] [Abstract][Full Text] [Related]
25. Estimating the cost of implementing a facility and community score card for maternal and newborn care service delivery in a rural district in Uganda.
Ssebagereka A; Apolot RR; Nyachwo EB; Ekirapa-Kiracho E
Int J Equity Health; 2021 Jan; 20(1):2. PubMed ID: 33386074
[TBL] [Abstract][Full Text] [Related]
26. [Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population].
Si YQ; Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Liu JJ; Gao P; Hu YH
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):443-449. PubMed ID: 29930411
[TBL] [Abstract][Full Text] [Related]
27. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
28. An economic evaluation of intermittent cyclosporin A therapy versus UVAB phototherapy in the treatment of patients with severe atopic dermatitis.
Salo H; Pekurinen M; Granlund H; Nuutinen M; Erkko P; Reitamo S
Acta Derm Venereol; 2004; 84(2):138-41. PubMed ID: 15206694
[TBL] [Abstract][Full Text] [Related]
29. Estimated cost for cardiovascular disease risk-based management at a primary healthcare center in Nepal.
Aryal A; Citrin D; Halliday S; Kumar A; Nepal P; Shrestha A; Nugent R; Schwarz D
Glob Health Res Policy; 2020; 5():2. PubMed ID: 32016159
[TBL] [Abstract][Full Text] [Related]
30. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
31. Patterns of healthcare utilization and costs for vascular dementia in a community-dwelling population.
Hill J; Fillit H; Shah SN; del Valle MC; Futterman R
J Alzheimers Dis; 2005 Sep; 8(1):43-50. PubMed ID: 16155348
[TBL] [Abstract][Full Text] [Related]
32. Feasibility and affordability of cardiovascular disease prevention in sub-Saharan Africa.
Fagard RH
J Hypertens; 2015 Feb; 33(2):260-2. PubMed ID: 25535878
[No Abstract] [Full Text] [Related]
33. Cost effectiveness of cardiovascular disease prevention strategies: a perspective on EU food based dietary guidelines.
Brunner E; Cohen D; Toon L
Public Health Nutr; 2001 Apr; 4(2B):711-5. PubMed ID: 11683566
[TBL] [Abstract][Full Text] [Related]
34. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
35. Estimating the costs of psychiatric hospital services at a public health facility in Nigeria.
Ezenduka C; Ichoku H; Ochonma O
J Ment Health Policy Econ; 2012 Sep; 15(3):139-48. PubMed ID: 23001282
[TBL] [Abstract][Full Text] [Related]
36. How much does effective health facility inspection cost? An analysis of the economic costs of Kenya's Joint Health Inspection innovations.
Chege T; Wafula F; Tama E; Khayoni I; Ogira D; Gitau N; Goodman C
BMC Health Serv Res; 2022 Nov; 22(1):1351. PubMed ID: 36376860
[TBL] [Abstract][Full Text] [Related]
37. Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya.
Shen J; Olwanda E; Kahn JG; Huchko MJ
BMC Health Serv Res; 2018 May; 18(1):378. PubMed ID: 29801496
[TBL] [Abstract][Full Text] [Related]
38. WHO/ISH total risk approach for primary prevention of cardiovascular disease shows greater decrease in costs for women but not the elderly in Jamaica.
Abdulkadri AO; Tulloch-Reid MK; Francis DK; Gordon-Strachan GM; Younger-Coleman NO; Rocke KD; McFarlane SR; Cunningham-Myrie CA; Ferguson TS; Wilks RJ; Anderson SG
J Clin Epidemiol; 2015 Sep; 68(9):994-1001. PubMed ID: 25819490
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy.
Bovet P; Shamlaye C; Gabriel A; Riesen W; Paccaud F
BMC Public Health; 2006 Jan; 6():9. PubMed ID: 16423280
[TBL] [Abstract][Full Text] [Related]
40. Economic analysis of a school-based obesity prevention program.
Wang LY; Yang Q; Lowry R; Wechsler H
Obes Res; 2003 Nov; 11(11):1313-24. PubMed ID: 14627751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
